Linezolid CAS 165800-03-3 Assay 98.0~102.0%

Short Description:

Chemical Name: Linezolid 

CAS: 165800-03-3

Assay: 98.0~102.0% 

Appearance: White to Off-White Crystalline Powder

Contact: Dr. Alvin Huang 

Mobile/Wechat/WhatsApp: +86-15026746401 

E-Mail: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Description:

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer of Linezolid (CAS: 165800-03-3) with high quality. Ruifu Chemical can provide worldwide delivery, competitive price, excellent service, small and bulk quantities available. Purchase Linezolid (CAS: 165800-03-3), Please contact: alvin@ruifuchem.com

Intermediates of Linezolid:

Chemical Properties:

Chemical Name Linezolid  
Synonyms (S)-N-[[3-(3-Fluoro-4-Morpholinophenyl)-2-Oxooxazolidin-5-yl]methyl]acetamide; N-[[(5S)-3-[3-Fluoro-4-(4-Morpholinyl)phenyl]-2-Oxo-5-Oxazolidinyl]methyl]-Acetamide; N-[[(5S)-3-(3-Fluoro-4-Morpholin-4-ylphenyl)-2-Oxo-1,3-Oxazolidin-5-yl]methyl]acetamide; Linospan; Linox; PNU 100766; U 100766; Zyvox; Zyvoxid
Stock Status In Stock, Commercial Production  
CAS Number 165800-03-3
Molecular Formula C16H20FN3O4
Molecular Weight 337.35 g/mol
Melting Point 177.0 to 181.0℃ 
Density 1.302±0.06 g/cm3 
Sensitive Air Sensitive  
Water Solubility  Insoluble in Water, 610 mg/l 25℃
Solubility  Slightly Soluble in Dichloromethane; Insoluble in Ethanol
COA & MSDS Available
Origin Shanghai, China
Brand Ruifu Chemical

Specifications:

Items Inspection Standards Results
Appearance White to Off-White Crystalline Powder White Crystalline Powder      
Assay 98.0~102.0%  99.75%
Specific Rotation -9.0° to -14.0° -11.05°
Loss on Drying <1.00%   0.09%
Residue on Ignition <0.20%  0.07%
Related Substances
Max. Single Impurity  <0.50%  Complies       
Any Unknown Impurity           <0.50%  Complies       
Total Impurities <1.00%   Complies    
Heavy Metals <20ppm <20ppm
Infrared Spectrum  Consistent with Structure  Complies  
1H NMR Spectrum  Consistent with Structure  Complies  
Conclusion  The product has been tested and complies with the given specifications  

Package/Storage/Shipping:

Package: Fluorinated Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement.
Storage Condition: Keep the container tightly closed and store in a cool, dry and well-ventilated warehouse away from incompatible substances. Protect from light and moisture.
Shipping: Deliver to worldwide by air, by FedEx / DHL Express. Provide fast and reliable delivery. 

Advantages:

Sufficient Capacity: Sufficient facilities and technicians

Professional Service: One stop purchasing service

OEM Package: Custom package and label available

Fast Delivery: If within stock, three days delivery guaranteed

Stable Supply: Maintain reasonable stock    

Technical Support: Technology solution available

Custom Synthesis Service: Ranged from grams to kilos

High Quality: Established a complete quality assurance system

FAQ:

How to Purchase? Please contact Dr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com 
15 Years Experience? We have more than 15 years of experience in the manufacture and export of a wide range of high quality pharmaceutical intermediates or fine chemicals.
Main Markets? Sell to domestic market, North America, Europe, India, Korea, Japanese, Australia, etc.
Advantages? Superior quality, affordable price, professional services and technical support, fast delivery.
Quality AssuranceStrict quality control system. Professional equipment for analysis include NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, K.F, ROI, LOD, MP, Clarity, Solubility, Microbial limit test, etc.
SamplesMost products provide free samples for quality evaluation, shipping cost should be paid by customers.
Factory AuditFactory audit welcome. Please make an appointment in advance.
MOQ? No MOQ. Small order is acceptable.
Delivery Time? If within stock, three days delivery guaranteed.
TransportationBy Express (FedEx, DHL), by Air, by Sea.
Documents? After sales service: COA, MOA, ROS, MSDS, etc. can be provided.
Custom SynthesisCan provide custom synthesis services to best fit your research needs.
Payment TermsProforma invoice will be sent first after confirmation of order, enclosed our bank information. Payment by T/T (Telex Transfer), PayPal, Western Union, etc. 

165800-03-3 - Safety Information:

Hazard Symbols Xn - Harmful
Risk Codes 20/21/22 - Harmful by inhalation, in contact with skin and if swallowed.
Safety Description S36 - Wear suitable protective clothing.
S24/25 - Avoid contact with skin and eyes.
WGK Germany 3
RTECS AC2720000
HS Code 2942000000

165800-03-3 - Application:

Linezolid (CAS: 165800-03-3) is a new type of azolidinone synthetic antibacterial drug developed and produced by Pharmacia & Upiohn Company (acquired by Pfizer), which was approved by FDA on April 18, 2000. This product is the first drug approved for the treatment of methicillin-resistant Staphylococcus aureus infection in the United States in 40 years. It was listed in my country in September 2007 and belongs to medical insurance Class B drugs.

165800-03-3 - Indications:

For the treatment of Gram-positive (G +) bacteria caused infections, including concurrent bacteremia;  nosocomial pneumonia;  community-acquired pneumonia ( because bacteria are not the same,pneumonia is clinically divided into hospital-acquired pneumonia and community-acquired pneumonia) and concomitant bacteremia;  it can be applied for the complexity of the skin and skin and soft tissue infections, including osteomyelitis in diabetic foot infections;  uncomplicated skin and skin and soft tissue infections;  it is also used for the treatment of vancomycin-resistant feces enterococci. 

165800-03-3 - Biological Activity:

Oxazolidinone antibiotic. Inhibits bacterial protein synthesis prior to chain initiation. Displays potent antibacterial activity against a variety of multidrug-resistant gram-positive microbes in vitro and in vivo.

165800-03-3 - Mechanism of Action:

The mechanism of action is inhibition of protein synthesis, but at a stage different from that of other protein synthesis inhibitors. The oxazolidinones bind to the 23S rRNA of the 50S subparticle to prevent formation of a functional 70S initiation complex. It is considered to be bacteriostatic against enterococci and staphylococci but bacteriocidal against streptococci. Resistance to oxazolidinones is encountered in the clinic because of a mutation in the 23S rRNA. This is believed to distort the linezolid binding site. Gram-negative microorganisms are intrinsically resistant to linezolid because of the presence of endogenous efflux pumps that keep it from accumulating in the cells.    

  • Write your message here and send it to us